Pages that link to "Q33959341"

The following pages link to Therapeutic action of the mitochondria-targeted antioxidant SkQ1 on retinopathy in OXYS rats linked with improvement of VEGF and PEDF gene expression (Q33959341):

Displaying 25 items.

• SkQ1 Ophthalmic Solution for Dry Eye Treatment: Results of a Phase 2 Safety and Efficacy Clinical Study in the Environment and During Challenge in the Controlled Adverse Environment Model (Q27342865) (← links)
• Genes of susceptibility to early neurodegenerative changes in the rat retina and brain: analysis by means of congenic strains (Q28559519) (← links)
• Senescence-accelerated OXYS rats: a model of age-related cognitive decline with relevance to abnormalities in Alzheimer disease (Q30760387) (← links)
• Disruption of Angiogenesis by Anthocyanin-Rich Extracts of Hibiscus sabdariffa (Q33614936) (← links)
• Mitochondrial expression and activity of P-glycoprotein under oxidative stress in outer blood-retinal barrier (Q33912457) (← links)
• Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium. (Q34217613) (← links)
• Pathological consequences of long-term mitochondrial oxidative stress in the mouse retinal pigment epithelium (Q36165326) (← links)
• Rat retinal transcriptome: effects of aging and AMD-like retinopathy (Q37018247) (← links)
• Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress (Q37369860) (← links)
• Consequences of oxidative stress in age-related macular degeneration (Q38003229) (← links)
• Reproducible effects of the mitochondria-targeted plastoquinone derivative SkQ1 on Drosophila melanogaster lifespan under different experimental scenarios (Q38429799) (← links)
• Effects of low-intensity ultrasound on oxidative damage in retinal pigment epithelial cells in vitro (Q38905581) (← links)
• An antioxidant specifically targeting mitochondria delays progression of Alzheimer's disease-like pathology. (Q39281122) (← links)
• The mitochondria-targeted antioxidant SkQ1 restores αB-crystallin expression and protects against AMD-like retinopathy in OXYS rats (Q42126431) (← links)
• Contributions of age-related alterations of the retinal pigment epithelium and of glia to the AMD-like pathology in OXYS rats. (Q42326574) (← links)
• The Mitochondria-Targeted Antioxidant SkQ1 Downregulates Aryl Hydrocarbon Receptor-Dependent Genes in the Retina of OXYS Rats with AMD-Like Retinopathy (Q42772602) (← links)
• Mitochondria and Angiogenesis (Q46359827) (← links)
• Association of AMD-like retinopathy development with an Alzheimer's disease metabolic pathway in OXYS rats. (Q47744270) (← links)
• Melatonin attenuates impairments of structural hippocampal neuroplasticity in OXYS rats during active progression of Alzheimer's disease-like pathology (Q48169931) (← links)
• Ameliorative effects of SkQ1 eye drops on cataractogenesis in senescence-accelerated OXYS rats. (Q51048745) (← links)
• Effect of SkQ1 eye drops on the rat lens metabolomic composition and the chaperone activity of α-crystallin. (Q53659360) (← links)
• Immunohistochemical localization of NGF, BDNF, and their receptors in a normal and AMD-like rat retina (Q64096907) (← links)
• Suppression of AMD-Like Pathology by Mitochondria-Targeted Antioxidant SkQ1 Is Associated with a Decrease in the Accumulation of Amyloid β and in mTOR Activity (Q92816070) (← links)
• PU-91 drug rescues human age-related macular degeneration RPE cells; implications for AMD therapeutics (Q93063267) (← links)
• Mitochondria-Targeted Drugs (Q93385793) (← links)